title: [Free radical processes in patients with the gastro-intestinal bleedings].
abstract: The role of the free radical processes (FRP) is shown and objectified in the development of the ulcer gastro-intestinal bleedings (UGIB). It is revealed on the first day of hospitalization already. The greatest imbalance of the FRP is registered in heavy patients with acute UGIB. It appeared like decrease of the oxygen and activation of the lipid FRP disregulation. Unheavy patients have FRP changes refer to the oxygen part of the oxidation process only. Intensification FRP in process of increase of weight disease consists in decrease activity oxygen and increase a lipid disbalance. FRP disbalance has long time proceeds, last till the patient's discharge. Results of the research prove as much as possible early inclusion in a complex of medical actions antoixidant therapy. The high efficiency of the energetic corrector reamberin in a dose of 400-800 ml was shown in patients with UGIB.
authors.forename: E V
authors.initials: EV
authors.lastname: Silina
authors.forename: V A
authors.initials: VA
authors.lastname: Stupin
authors.forename: M A
authors.initials: MA
authors.lastname: Sabirov
authors.forename: S B
authors.initials: SB
authors.lastname: Bolevich
authors.forename: G O
authors.initials: GO
authors.lastname: Smirnova
authors.forename: S V
authors.initials: SV
authors.lastname: Siluianov
authors.forename: A V
authors.initials: AV
authors.lastname: Martirosov
authors.forename: N I
authors.initials: NI
authors.lastname: Men'shova
mesh_terms: D000975:Antioxidants / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004381:Duodenal Ulcer / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D005609:Free Radicals / Q000378:metabolism*; D006801:Humans; D007262:Infusions, Intravenous; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008536:Meglumine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008875:Middle Aged; D010084:Oxidation-Reduction / Q000187:drug effects; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D012720:Severity of Illness Index; D013276:Stomach Ulcer / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D013386:Succinates / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D000975:Antioxidants; D005609:Free Radicals; C549374:Reamberin; D013386:Succinates; D008536:Meglumine